Ozen K Basoglu Selected Research

Homocysteine

7/2011

Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ozen K Basoglu Research Topics

Disease

13	Obstructive Sleep Apnea 08/2023 - 07/2011
7	Sleep Apnea Syndromes (Sleep Apnea) 08/2023 - 07/2011
5	Apnea 08/2023 - 01/2018
3	Hypoxia (Hypoxemia) 05/2023 - 12/2021
3	Pneumonia (Pneumonitis) 01/2022 - 01/2011
3	Cough 01/2017 - 10/2005
3	Dyspnea (Shortness of Breath) 01/2017 - 10/2005
2	Hypertension (High Blood Pressure) 05/2023 - 01/2023
2	COVID-19 01/2022 - 11/2020
2	Hypersensitivity (Allergy) 01/2017 - 08/2015
2	Periodontal Diseases (Periodontal Disease) 01/2015 - 07/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2023
1	Heart Failure 05/2023
1	Alcoholism (Alcohol Abuse) 01/2023
1	Hypercholesterolemia 01/2023
1	Hypothyroidism 01/2023
1	Obesity 01/2023
1	Fever (Fevers) 01/2022
1	Dyslipidemias (Dyslipidemia) 12/2021
1	Atherosclerosis 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021
1	Weight Loss (Weight Reduction) 10/2021
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2021
1	Sleep Wake Disorders 12/2018
1	Weight Gain 12/2018
1	Sleepiness 12/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2015
1	Gastroesophageal Reflux (GERD) 05/2015
1	Heartburn (Pyrosis) 05/2015
1	Insulin Resistance 07/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2011
1	Respiratory Insufficiency (Respiratory Failure) 01/2011
1	Asthma (Bronchial Asthma) 10/2005
1	Inflammation (Inflammations) 10/2005

Drug/Important Bio-Agent (IBA)

6	LipidsIBA 08/2023 - 07/2011
4	Oxygen (Dioxygen)IBA 05/2023 - 01/2018
3	HDL CholesterolIBA 08/2023 - 12/2021
3	CholesterolIBA 08/2023 - 11/2020
3	LDL CholesterolIBA 08/2023 - 12/2021
3	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 10/2005
3	Adenosine Monophosphate (AMP)IBA 01/2017 - 10/2005
3	Adenosine Triphosphate (ATP)IBA 01/2017 - 10/2005
2	Triglycerides (Triacylglycerol)IBA 08/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2020
1	R 111IBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2023
1	favipiravirIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2021
1	HDL LipoproteinsIBA 12/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2021
1	Indicators and Reagents (Reagents)IBA 12/2018
1	Capsaicin (Zostrix)FDA Link 01/2017
1	AcidsIBA 05/2015
1	Collagenases (Collagenase)FDA Link 01/2015
1	CytokinesIBA 07/2014
1	HomocysteineIBA 07/2011
1	Fibrinogen (Factor I)FDA Link 07/2011
1	Glucose (Dextrose)FDA LinkGeneric 07/2011
1	C-Reactive ProteinIBA 07/2011
1	LeptinIBA 07/2011

Therapy/Procedure

5	Therapeutics 12/2021 - 12/2012
3	Continuous Positive Airway Pressure 01/2021 - 12/2012
1	Palatal Expansion Technique 01/2023
1	Duration of Therapy 12/2018
1	Artificial Respiration (Mechanical Ventilation) 01/2011